Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Paxene receives marketing approval in Canada for Kaposi's sarcoma

May 2, 2000

ImClone Systems receives notice of allowability for cancer immunotherapy

May 2, 2000

Aphton begins trial of anti-G17 immunogen in metastatic gastric cancer

May 2, 2000

Novel platinum antitumor agent compares favorably with cisplatin in preclinical studies

May 2, 2000

Selectin inhibitors under study by Otsuka

May 2, 2000

Treatment and diagnosis of tumors using urokinase inhibitors

May 2, 2000

Swainsonine analogues in development at GlycoDesign as therapeutic agents

May 2, 2000

American Cyanamid describes new inhibitors of growth factor receptor PTKs useful in cancer Rx

May 2, 2000

Licensing opportunity from NIH: antibodies and immunotoxins for treating, diagnosing cancer

April 28, 2000

Licensing opportunity from NIH: MAb for the treatment, diagnosis of prostate cancer

April 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...